MedTrace Logo

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

NCT03827694 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-09-25

No results posted yet for this study

Summary

This study will establish a non-invasive diagnostic approach and evaluate clinical outcomes for children at high-risk for pulmonary invasive fungal infection (PIFI).

Conditions

  • Pulmonary Invasive Fungal Infections
  • Pulmonary Invasive Aspergillosis

Interventions

DIAGNOSTIC_TEST

Non-Invasive Testing for PIFI

galactomannan assay, fungal PCRs, cell-free next-generation DNA/RNA sequencing, RNAseq

Sponsors & Collaborators

  • Children's Hospital of Philadelphia

    collaborator OTHER

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Arkansas Children's Hospital Research Institute

    lead OTHER

Principal Investigators

  • William Steinbach · University of Arkansas

  • Brian Fisher · Children's Hospital of Philadelphia

Eligibility

Min Age
120 Days
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-30
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03827694 on ClinicalTrials.gov